⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7749096 | 0.97 | HTT (0.45) | — | |
| SCHEMBL7749230 | 0.97 | HTT (0.45) | — | |
| Hydrochloric Acid SCHEMBL27321583 | 0.97 | HTT (0.41) | — | |
| SCHEMBL7747487 | 0.97 | HTT (0.45) | — | |
| SCHEMBL1259794 | 0.97 | HTT (0.45) | — | |
| SCHEMBL15282042 | 0.97 | HTT (0.45) | — | |
| Hydrochloric Acid SCHEMBL27543811 | 0.95 | HTT (0.44) | — | |
| Hydrochloric Acid SCHEMBL27317890 | 0.95 | HTT (0.44) | — | |
| SCHEMBL1259613 | 0.94 | — | — | |
| SCHEMBL4778404 | 0.88 | CA2 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120025515-A | Room-temperature self-repairing tough polyurethane elastomer and preparation method and application thereof | 中国科学院化学研究所 | 2025-05-23 | — | — | CN | claimed |
| US-20250129429-A1 | GENE FUSIONS IN SARCOMA | FOUNDATION MEDICINE, INC. (US) | 2025-04-24 | — | — | US | claimed |
| EP-4423302-A2 | NOVEL KINASE FUSIONS DETECTED BY LIQUID BIOPSY | Foundation Medicine, Inc. (US) | 2024-09-04 | — | — | EP | claimed |
| CN-118414439-A | Novel kinase fusion by liquid biopsy | 基金会医学公司 | 2024-07-30 | — | — | CN | claimed |
| EP-4399330-A1 | GENE FUSIONS IN SARCOMA | Foundation Medicine, Inc. (US) | 2024-07-17 | — | — | EP | claimed |
| WO-2023077104-A2 | NOVEL KINASE FUSIONS DETECTED BY LIQUID BIOPSY | FOUNDATION MEDICINE, INC. (US) | 2023-05-04 | — | — | WO | claimed |
| WO-2023039539-A1 | GENE FUSIONS IN SARCOMA | FOUNDATION MEDICINE, INC. (US) | 2023-03-16 | — | — | WO | claimed |
| US-11578372-B2 | NTRK1 fusion molecules and uses thereof | FOUNDATION MEDICINE, INC. (US) | 2023-02-14 | — | — | US | claimed |
| US-20220243280-A1 | NTRK FUSION MOLECULES AND USES THEREOF | FOUNDATION MEDICINE, INC. (US) | 2022-08-04 | — | — | US | claimed |
| EP-3980563-A2 | NTRK FUSION MOLECULES AND USES THEREOF | Foundation Medicine, Inc. (US) | 2022-04-13 | — | — | EP | claimed |
| WO-2020243021-A2 | NTRK FUSION MOLECULES AND USES THEREOF | FOUNDATION MEDICINE, INC. (US) | 2020-12-03 | — | — | WO | claimed |
| US-20200299775-A1 | NOVEL NTRK1 FUSION MOLECULES AND USES THEREOF | FOUNDATION MEDICINE, INC. | 2020-09-24 | — | — | US | claimed |
| EP-2914621-A2 | NOVEL NTRK1 FUSION MOLECULES AND USES THEREOF | Foundation Medicine, Inc. (US) | 2015-09-09 | — | — | EP | claimed |
| US-20150073036-A1 | NOVEL NTRK1 FUSION MOLECULES AND USES THEREOF | FOUNDATION MEDICINE, INC. | 2015-03-12 | — | — | US | claimed |
| WO-2014071358-A2 | NOVEL NTRK1 FUSION MOLECULES AND USES THEREOF | FOUNDATION MEDICINE, INC. (US) | 2014-05-08 | — | — | WO | claimed |
| US-6433024-B1 | WATER, BENZOYL PEROXIDE, ISOSORBIDE DIESTER, DETERGENT, MOISTURIZER; AND LACTIC, GLYCOLIC, MALIC, OR 2-HYDROXYDECANOIC ACID; SENSITIVE CREAM | STIEFEL LABORATORIES, INC. | 2002-08-13 | — | — | US | claimed |
| CN-1327418-A | Metallic ink composition for wick type writing instruments | DRI MARK PRODUCTS INC (US) | 2001-12-19 | — | — | CN | claimed |
| WO-2001085159-A1 | TOPICAL ANTI-ACNE COMPOSITION | STIEFEL LABORATORIES, INC. (US) | 2001-11-15 | — | — | WO | claimed |
| CN-118515652-B | Crystal form of pyrrolidinyl urea derivative and application thereof | 漳州片仔癀药业股份有限公司 | 2025-11-07 | — | — | CN | disclosed |
| EP-0083096-A2 | Production of urethane compounds | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1983-07-06 | — | — | EP | disclosed |